Member Info for baldingquickly

Agreed. This isn’t make or break at all, but I guarantee it will impact sentiment and therefore SP. A vaccine wasn’t make or break for us for example either, and look where we find ourselves. Just keep holding and we will be back to £1 in the new year, perhaps a bit sooner with MHRA and some confirmed orders.

I was absolutely devastated with the SP yesterday, my average price was over 90p. Not sure if I am just justifying it to myself, but my position is that a vaccine is a great step forward for ODX and the world. Speaking about ODX only:
1. We have been saying for months that an Antibody test will complement a vaccine. ODXs diversification is what attracted me to begin with.
2. Even if UK are front of the queue for the vaccine, most of the world are not. We have been saying for months that international orders is where we could make big money.
3. The fact these trials have been so quick will give everyone pause to take the vaccine. I would pay £500 for each of the family to take an antibody test before opting for the vaccine to avoid it if possible (I am a huge vaccine supporter ordinarily). Private testing has been opened right up for the (non-vulnerable) general public (vulnerable getting a test through gov before vaccine administration being my thought process).

Any challenges or validations of the above would be appreciated.

Hopefully changing tack will have the opposite effect Spurs. I like it. Haha

As someone who has only recently been introduced to AIM, I struggle to fathom how after two decent RNS releases, we have closed down significantly by close of play. Surely it is not all MMs? I have built up from £5,000 to £22,000 holding over the past 6 weeks (average now ~97p) and planning to hold for a while yet, but please help us newbies understand :(

The government order of 1m tests was confirmed the evening before which sent it to 125.

Could it be 50m plastic mouldings multiplied by a £10 price that Zengha is drawing a conclusion from?

Please don't slate me as I am new to this (first post!), but aren't earning multipliers partly based on expected years of revenue streams? While undoubtedly in a great position, surely a 3x multiplier would be about max for COVID only revenues. Happy for anyone to point out flaws in my logic as I learn trading and the AIM market, and of course would still lead to ~3x above current market cap.